Vaccine for Human Use Imports in Central America Al December 31st, 2020  

CentralAmericaDataINFORMACIÓN DE MERCADOS

Complete el formulario, en breve nos comunicaremos con usted:

Your message has been sent. We will contact you shortly.

Name*

Last Name*

Email:*

Telephone (Country):*

Company:*

Title:*

Size of the Company:* Choose one... Less than 100 employees Between 100 and 500 Between 500 and 2500 More than 2500

Industry:* -None- Agro Alimentos y bebidas Construcción e infraestructura Banca y finanzas Farmacéutica y salud Servicios Retail Automotriz Energía y minería Química y plástico Bienes Raíces Educación Bienes de consumo Industria y manufactura Transporte y logística Telecomunicaciones Administración pública

Yes, I want to receive a call from a salesperson*

Comments:*  

this site is protected by reCAPTCHA and Google's privacy policy and terms of service.

Need assistance? Contact us

(506) 4001-6423

CentralAmericaData is the leading B2B market research company in Central America. We specialize in compiling, validating and analyzing data from the economic activities in Central American and South American countries, along with Mexico. We provide our clients and companies with presence in the region relevant information to define business strategies and make adequate decisions. Learn more about our services here

2008 - 2021 © CentralAmericaData Todos los derechos reservados

Figures from the Trade Intelligence Unit of CentralAmericaData: Click to interact with the graphClick to interact with the graph

Explore the data in the interactive display.

Panamanian and Guatemalan Companies, Main Buyers
In 2020 the main importer of vaccines for human use in Central America was Guatemala, with $35 million, followed by Costa Rica, with $27 million, Panama, with $25 million, Honduras, with $17 million, El Salvador, with $16 million and Nicaragua, with $14 million.

One of the six countries recorded a year-on-year increase in purchases. In Nicaragua, imports increased 21%.

El Salvador, Costa Rica, Guatemala, Honduras and Panama were the markets that registered negative variations, reporting decreases of 7%, 8%, 26%, 33% and 65%, respectively.

Regional Business Variation
Between 2019 and 2020, the value imported into the region decreased considerably, going from $203 million to $134 million, which is equivalent to a variation of -34%.

In contrast to the behavior of regional imports, for the periods in question, purchases from companies in Russia increased from $5 million to $7.7 million, equivalent to a variation of 54%.

USA and Belgium, Main Suppliers
In 2020, 25% of the value imported into the region came from the USA, 22% from Belgium, 9% from the Netherlands, 9% from India, 8% from South Korea, 8% from France and 6% from Russia.

Purchases from the U.S. have lost ground in recent years, accounting for 44% of total regional imports in 2010 and falling to 25% in 2020.

Do you know that we are now part of something bigger?
Learn about PREDIK Data-Driven, our new global brand.

Do you need Business Intelligence solutions for the medical products market? Contact Us

Your message has been sent. We will contact you shortly.

Name*

Last Name*

Email:*

Telephone (Country):*

Company:*

Title:*

Size of the Company:* Choose one... Less than 100 employees Between 100 and 500 Between 500 and 2500 More than 2500

Industry:* -None- Agro Alimentos y bebidas Construcción e infraestructura Banca y finanzas Farmacéutica y salud Servicios Retail Automotriz Energía y minería Química y plástico Bienes Raíces Educación Bienes de consumo Industria y manufactura Transporte y logística Telecomunicaciones Administración pública

Yes, I want to receive a call from a salesperson*

Comments:*  

this site is protected by reCAPTCHA and Google's privacy policy and terms of service.

Need assistance? Contact us

(506) 4001-6423

More on this topic

Medicines: Purchases Exceed $3.5 Billion

May 2021

During 2020, Central American imports of pharmaceutical products totaled $3.502 billion, and purchases from Mexican companies increased by 2% over the amount reported in 2019.

Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]

Human Vaccines: Business with Russia is Increasing

March 2021

From January to September 2020, companies in the region invested $101 million for the purchase abroad of vaccines for human use, and purchases from Russian companies increased 34% compared to the same period in 2019.

Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]

Vaccines for Human Use: Business in the Region

September 2020

From January to March 2020, companies in the region bought vaccines for human use abroad for $28 million, and 56% of total imports were made by companies in Costa Rica and Panama.

Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]

Vaccines: Purchases Up 11% in 2018

June 2019

In 2018, purchases of vaccines for human use in Central America totaled $141 million, 11% more than reported in 2017.

Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]